STILAMIN

Welcome to the Brand page for “STILAMIN”, which is offered here for In the statement, column 1, line 1, new york should be deleted and massachusetts should be inserted.;somatostatin used for the treatment of gastrointestinal hemorrhaging, inflammation of the pancreas, diseases of the liver and psoriasis;.

Its status is currently believed to be active. Its class is unavailable. “STILAMIN” is believed to be currently owned by “SERONO LABORATORIES, INC.”


Owner:
SERONO LABORATORIES, INC.
Owner Details
Description:
IN THE STATEMENT, COLUMN 1, LINE 1, NEW YORK SHOULD BE DELETED AND MASSACHUSETTS SHOULD BE INSERTED.;Somatostatin Used for the Treatment of Gastrointestinal Hemorrhaging, Inflammation of the Pancreas, Diseases of the Liver and Psoriasis;
Categories: IN STATEMENT